Posted in | News | Diamond

Botswana Diamonds Plans IPO

Botswana Diamonds is ready to list on the Botswana Stock Exchange by the end of February as per company officials. However the Botswana Stock Exchange said Friday that it had not received an listing application as of yet.

Investors who are interested in the company hope to get an introductory price of 0.71 Pula per share that will put the Botswana Diamonds company at a value of around £7 million. The company holds exploration licenses in Botswana besides other investments which include a 35.42 percent stake in a company with exploration interests in the Democratic Republic of Congo, a small shareholding in AIM-quoted Stellar Diamonds. It also has around $2m in cash.

The company Botswana Diamonds, is actually a spin off from the AIM company African Diamonds which delisted from the Botswana Stock Exchange when it was acquired by Lucara Diamonds in late 2010. They also hope to join the London bourse in the beginning of next month. They also have plans to invest in projects in Cameroon and Zimbabwe.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, March 19). Botswana Diamonds Plans IPO. AZoMining. Retrieved on April 26, 2024 from https://www.azomining.com/News.aspx?newsID=2786.

  • MLA

    Chai, Cameron. "Botswana Diamonds Plans IPO". AZoMining. 26 April 2024. <https://www.azomining.com/News.aspx?newsID=2786>.

  • Chicago

    Chai, Cameron. "Botswana Diamonds Plans IPO". AZoMining. https://www.azomining.com/News.aspx?newsID=2786. (accessed April 26, 2024).

  • Harvard

    Chai, Cameron. 2019. Botswana Diamonds Plans IPO. AZoMining, viewed 26 April 2024, https://www.azomining.com/News.aspx?newsID=2786.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.